Correlation Between Stoke Therapeutics and Graphite Bio
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Graphite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Graphite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Graphite Bio, you can compare the effects of market volatilities on Stoke Therapeutics and Graphite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Graphite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Graphite Bio.
Diversification Opportunities for Stoke Therapeutics and Graphite Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Stoke and Graphite is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Graphite Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Graphite Bio and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Graphite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Graphite Bio has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Graphite Bio go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Graphite Bio
If you would invest (100.00) in Graphite Bio on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Graphite Bio or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Stoke Therapeutics vs. Graphite Bio
Performance |
Timeline |
Stoke Therapeutics |
Graphite Bio |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Stoke Therapeutics and Graphite Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stoke Therapeutics and Graphite Bio
The main advantage of trading using opposite Stoke Therapeutics and Graphite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Graphite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Graphite Bio will offset losses from the drop in Graphite Bio's long position.Stoke Therapeutics vs. Mirum Pharmaceuticals | Stoke Therapeutics vs. Rocket Pharmaceuticals | Stoke Therapeutics vs. Avidity Biosciences | Stoke Therapeutics vs. Uniqure NV |
Graphite Bio vs. Assembly Biosciences | Graphite Bio vs. Instil Bio | Graphite Bio vs. Nuvation Bio | Graphite Bio vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |